𧬠Exomiser
What is Exomiser?
Exomiser is a phenotype-driven variant and gene prioritization tool designed for
next-generation sequencing (NGS) analysis in Mendelian disease.
It integrates genetic variant data with Human Phenotype Ontology (HPO) annotations
to rank candidate disease genes for diagnosis or novel gene discovery.
π Key References
-
Robinson PN et al. (2014)
Improved exome prioritization of disease genes through cross-species phenotype comparison.
Genome Research 24(2):340-348.
PMID:24162188 -
Smedley D (2015)
Next-generation diagnostics and disease-gene discovery with the Exomiser.
Nature Protocols 10(12):2004-2015.
PMID:26562621
π§ͺ Background
Exomiser was among the first phenotype-aware prioritization tools and was released in 2014
as a freely available Java application.
It requires two primary inputs:
- Genomic data
- A VCF file containing variants from a rare-disease patient
-
Optionally, a multi-sample VCF and a pedigree (
PED) file for family analyses -
Phenotypic data
- A list of HPO terms describing the patientβs clinical features
The algorithm combines variant pathogenicity predictions with phenotype similarity scoring across human and model-organism data.
π Online Demo
A demo version of Exomiser is available here:
π https://exomiser.monarchinitiative.org/exomiser/
𧬠Hands-On Exercise
Goal
Learn how phenotype-driven prioritization improves variant interpretation.
Download the provided example dataset containing:
- An exome from a healthy individual
- A causative FGFR2 variant associated with autosomal dominant Pfeiffer syndrome
Step 1 β Add Phenotypes
Add HPO terms describing Pfeiffer syndrome, similar to the workflow used in Phenomizer.
You may consult the HPO disease page:
π https://hpo.jax.org/app/browse/disease/OMIM:101600
Step 2 β Run Exomiser
You can:
- Run Exomiser using default settings, or
- Adjust parameters (see the publications above for detailed explanations).
π§Ύ Exercise 1
Explore the results
Examine the Exomiser output and answer the following:
- What are the top five candidate genes?
- What phenotypic evidence supports their ranking?
- What genetic evidence argues for or against each candidate?
Consider:
- Variant pathogenicity scores
- Phenotype similarity scores
- Mode of inheritance
- Geneβdisease associations
Next Module: Running Exomiser from command line